AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Clinical trial NCT03453489 · COMPLETED
Trial details
- NCT number
- NCT03453489
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2020-10-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.